India Ratings and Research forecasts a 10% growth for the Indian pharmaceutical industry in FY27, supported by strong ...
Eli Lilly has gained FDA approval for Olumiant to treat severe alopecia areata in children aged 12 and over, marking a ...
The decision followed discussions with the US Food and Drug Administration, which determined that the data from a mid-stage ...
Lupin Limited has received tentative approval from the FDA to market a generic version of Eliquis, a leading blood thinner ...
Sun Pharmaceuticals acquires rights to manufacture and market Lyrokaul, a novel PCSK9 inhibitor, enhancing treatment options for cholesterol management. Discover its benefits and market implications.
Mirum Pharmaceuticals' drug, Atebrioz (zilurgisertib), is now FDA-approved for treating fibrodysplasia ossificans progressive ...
Speaking at the Fourth edition of ETPharma's Future-Ready Supply Chain Summit, Pratap Gouda, Senior General Manager - IT, ...
Merck's latest clinical trial results reveal that remigromig is as effective as ranibizumab for treating diabetic macular ...
Sanofi Healthcare India purchases a 15.2% stake in Sanofi India, boosting its investment in the pharmaceutical giant. The ...
The Central Drugs Standard Control Organisation (CDSCO) intensifies its efforts to prevent the illegal diversion of ...
Bengaluru: The US Food and Drug Administration has approved AbbVie's drug for Parkinson's disease in adults, the health ...
The Haryana FDA's investigation into counterfeit Telma-AM tablets has led to two additional arrests, revealing a broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results